Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Crigler-jjar Syndrome - Overview
Crigler-jjar Syndrome - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Crigler-jjar Syndrome - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Crigler-jjar Syndrome - Companies Involved in Therapeutics Development
Intertiol Stem Cell Corp
Logicbio Therapeutics Inc
Promethera Biosciences SA
Selecta Biosciences Inc
Crigler-jjar Syndrome - Drug Profiles
Gene Therapy for Crigler-jjar Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GNT-0003 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HepaStem - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LB-301 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Alpha-Antitrypsin Deficiency, Crigler-jjar Syndrome and Liver Cirrhosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Crigler-jjar Syndrome - Dormant Projects
Crigler-jjar Syndrome - Product Development Milestones
Featured News & Press Releases
Feb 12, 2013: Intertiol Stem Cell Demonstrates Positive Animal Efficacy Results In Metabolic Liver Disease Program
Jan 07, 2013: Intertiol Stem Cell Announces Positive Animal Efficacy Results In Liver Disease Program
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Crigler-Najjar Syndrome, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Stage and Targets, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development for Crigler-Najjar Syndrome, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Crigler-Najjar Syndrome - Pipeline by International Stem Cell Corp, H1 2020
Crigler-Najjar Syndrome - Pipeline by Logicbio Therapeutics Inc, H1 2020
Crigler-Najjar Syndrome - Pipeline by Promethera Biosciences SA, H1 2020
Crigler-Najjar Syndrome - Pipeline by Selecta Biosciences Inc, H1 2020
Crigler-Najjar Syndrome - Dormant Projects, H1 2020